The House Committee on Energy and Commerce’s Subcommittee on Health Wednesday held a hearing to discuss COVID-19’s disproportionate effect on racial and ethnic minorities.

Witnesses for the hearing, titled "Health Care Inequality: Confronting Racial and Ethnic Disparities in COVID-19 and the Health Care System," were pediatrician Rhea Boyd, M.D., National Medical Association President Oliver T. Brooks, M.D., and Avik S. A. Roy, head of the Foundation for Research on Equal Opportunity.

The witnesses discussed the numerous contributing factors to racial disparities in COVID-19, including environmental racism and lack of access to clean water; housing segregation; and underrepresentation in, and lack of access to, clinical trials.

To further explore solutions, the committee is forming a racial disparities working group to be co-led by Rep. Yvette Clarke, D-N.Y.  Chairman Anna Eshoo, D-Calif., called on committee members who represent Native American communities and tribal nations to work together on recommendations to address COVID-19-related disparities that affect their constituents.

Related News Articles

Headline
In this conversation, Terry Scoggin, CEO of Titus Regional Medical Center, discusses how the organization designed a system of care to ensure that every…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The AHA’s Institute for Diversity and Health Equity will host its next Health Equity Innovation Summit in Washington, D.C., on Nov. 12 from 9:30 a.m. to 3:30 p…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…